| Compound Information | SONAR Target prediction | | Name: | EPICOPROSTEROL | | Unique Identifier: | SPE01504056 | | MolClass: | Checkout models in ver1.5 and ver1.0 | | Molecular Formula: | C27H48O | | Molecular Weight: | 341.296 g/mol | | X log p: | 1.606 (online calculus) | | Lipinksi Failures | 0 | | TPSA | 0 | | Hydrogen Bond Donor Count: | 0 | | Hydrogen Bond Acceptors Count: | 1 | | Rotatable Bond Count: | 5 | | Canonical Smiles: | CC(C)CCCC(C)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C | | Source: | ex mammalian excretions | | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | | Drug_type: | Experimental | | Drugbank_id: | EXPT00530 | | Logp: | 3.73 | | Drug_category: | Sex Hormone-Binding Globulin inhibitor | | Organisms_affected: | -1 |
| Species: |
4932 |
| Condition: |
APC9 |
| Replicates: |
2 |
| Raw OD Value: r im |
0.7092±0.00141421 |
| Normalized OD Score: sc h |
1.0044±0.00455083 |
| Z-Score: |
0.2403±0.250852 |
| p-Value: |
0.812984 |
| Z-Factor: |
-35.5461 |
| Fitness Defect: |
0.207 |
| Bioactivity Statement: |
Nonactive |
| Experimental Conditions | | | Library: | Spectrum | | Plate Number and Position: | 9|E5 | | Drug Concentration: | 50.00 nM | | OD Absorbance: | 600 nm | | Robot Temperature: | 23.00 Celcius | | Date: | 2007-11-22 YYYY-MM-DD | | Plate CH Control (+): | 0.041624999999999995±0.00032 | | Plate DMSO Control (-): | 0.684675±0.01815 | | Plate Z-Factor: | 0.9186 |
|  png
ps
pdf |
| 7829989 |
(5R,8S,9S,10S,13R,14R,16R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta
[a]phenanthren-16-ol |
| 10975445 |
(1R,4S,6S)-bicyclo[2.2.1]heptan-6-ol |
| 10975454 |
(1S)-2-methylcyclohexan-1-ol |
| 11075068 |
2-[(1R,4R,4aS,7S,8aS)-4,7-dimethyl-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl]propan-2-ol |
| 11076083 |
(2S,3S)-3,7-dimethylpentadecan-2-ol |
| 11475087 |
n/a |
| active | Cluster 2228 | Additional Members: 18 | Rows returned: 7 | 1 2 Next >> |
|
